China Health Group Inc. (HKG:8225)

China Health Group Statistics

Total Valuation

HKG:8225 has a market cap or net worth of HKD 123.42 million. The enterprise value is 96.52 million.

Market Cap	123.42M
Enterprise Value	96.52M

Important Dates

The last earnings date was Monday, March 30, 2026.

Earnings Date	Mar 30, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:8225 has 995.35 million shares outstanding.

Current Share Class	995.35M
Shares Outstanding	995.35M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	46.73%
Owned by Institutions (%)	n/a
Float	288.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.88
PB Ratio	2.03
P/TBV Ratio	2.00
P/FCF Ratio	14.64
P/OCF Ratio	14.62
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.80
EV / Sales	3.04
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	11.45

Financial Position

The company has a current ratio of 2.46

Current Ratio	2.46
Quick Ratio	2.03
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -24.04% and return on invested capital (ROIC) is -48.51%.

Return on Equity (ROE)	-24.04%
Return on Assets (ROA)	-10.07%
Return on Invested Capital (ROIC)	-48.51%
Return on Capital Employed (ROCE)	-27.66%
Weighted Average Cost of Capital (WACC)	1.96%
Revenue Per Employee	993,322
Profits Per Employee	-520,308
Employee Count	32
Asset Turnover	0.30
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.27% in the last 52 weeks. The beta is -0.42, so HKG:8225's price volatility has been lower than the market average.

Beta (5Y)	-0.42
52-Week Price Change	-27.27%
50-Day Moving Average	0.13
200-Day Moving Average	0.15
Relative Strength Index (RSI)	26.16
Average Volume (20 Days)	56,000

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:8225 had revenue of HKD 31.79 million and -16.65 million in losses. Loss per share was -0.02.

Revenue	31.79M
Gross Profit	18.24M
Operating Income	-16.85M
Pretax Income	-16.65M
Net Income	-16.65M
EBITDA	-16.04M
EBIT	-16.85M
Loss Per Share	-0.02

Balance Sheet

The company has 26.19 million in cash and n/a in debt, with a net cash position of 26.19 million or 0.03 per share.

Cash & Cash Equivalents	26.19M
Total Debt	n/a
Net Cash	26.19M
Net Cash Per Share	0.03
Equity (Book Value)	60.93M
Book Value Per Share	0.06
Working Capital	52.47M

Cash Flow

In the last 12 months, operating cash flow was 8.44 million and capital expenditures -11,128, giving a free cash flow of 8.43 million.

Operating Cash Flow	8.44M
Capital Expenditures	-11,128
Depreciation & Amortization	701,888
Net Borrowing	n/a
Free Cash Flow	8.43M
FCF Per Share	0.01

Margins

Gross margin is 57.39%, with operating and profit margins of -53.02% and -52.38%.

Gross Margin	57.39%
Operating Margin	-53.02%
Pretax Margin	-52.38%
Profit Margin	-52.38%
EBITDA Margin	-50.46%
EBIT Margin	-53.02%
FCF Margin	26.53%

Dividends & Yields

HKG:8225 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-13.49%
FCF Yield	6.83%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:8225 has an Altman Z-Score of 2.48 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.48
Piotroski F-Score	4